Table 3.
Study Design and Research Procedures
| Research procedures | Intervention period |
|||
|---|---|---|---|---|
| Visit 1 |
Visit 2 |
Visit 3 |
Visit 4 |
|
| Screening/pretreatment | Day 0 | Day 4 ± 1 Day | Day 7 ± 2 Days | |
| Assessment of eligibility | X | |||
| Informed consent | X | |||
| Medical history | X | |||
| Physical exam | X | |||
| Vital signs | X | X | X | X |
| Dressing application/change | X | X | X | |
| Wound and infection visual assessment | X | X | X | X |
| Wound photography | X | X | X | |
| Wound biopsy | X | X | ||
| Assess for adverse events | X | X | X | |
WED treatment was stopped at day 7. Subjects continued to participate in research visits at days 14 and 30 and wound closure (visual and TEWL) measurements and scar assessments was performed. These data are shown in Supplementary Data Content.
TEWL, transepidermal water loss; WED, wireless electroceutical dressing.